StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Synching news on Aristotle and Rexall news???

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Mar 26, 2021 3:06pm

132 Views

Post# 32887815

RE:Synching news on Aristotle and Rexall news???

Rexall just cut a deal with empower clinics. They are in our space so don't think stage and Rexall have anything.

https://stockhouse.com/news/press-releases/2021/02/09/empower-partners-with-rexall-r-to-launch-integrated-healthcare-centres

ScienceFirst wrote: Possible that they want to hit big with a synched news on Aristotle launch (cancer) and a Covid-19 testing partnership with Rexall chain of pharmacies weeks apart.

That would create quite an amazing impact! And the share price would clearly explode.

They could even gain visibility for Aristotle @Rexall, when offering COVID-19 testing! Remember that "Come for COVID-19, stay for cancer" slogan?

That could explain with the last real news release was Dec. 2 (Initiation of Testing for Travel to China). Maybe they have been that busy.